Td Asset Management Inc Halozyme Therapeutics, Inc. Transaction History
Td Asset Management Inc
- $102 Billion
- Q1 2025
A detailed history of Td Asset Management Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 1,451,842 shares of HALO stock, worth $77.7 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,451,842
Previous 1,372,134
5.81%
Holding current value
$77.7 Million
Previous $65.6 Million
41.22%
% of portfolio
0.09%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$944 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$687 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$324 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$209 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$197 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.46B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...